Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DPH.L Stock Summary
In the News
DPH.L Financial details
Company Rating
Buy
Market Cap
4.4B
Income
-27.9M
Revenue
761.5M
Book val./share
6.63
Cash/share
0.65
Dividend
0.13
Dividend %
0%
Employees
2.46K
Optionable
No
Shortable
Yes
Earnings
26 Feb 2024
P/E
-157.58
Forward P/E
3681.9
PEG
10.89
P/S
5.78
P/B
5.82
P/C
5947.69
P/FCF
107.82
Quick Ratio
0.45
Current Ratio
2.85
Debt / Equity
0.67
LT Debt / Equity
0.66
-
-
EPS (TTM)
-0.24
EPS next Y
1.05
EPS next Q
-
EPS this Y
-144.44%
EPS next Y
-534.92%
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
9.59%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
0.66%
SMA50
2.07%
SMA100
-
Inst Own
0.12%
Inst Trans
0.23%
ROA
-2%
ROE
-6%
ROC
0.01%
Gross Margin
56%
Oper. Margin
2%
Profit Margin
-4%
Payout
-185%
Shs Outstand
113.91M
Shs Float
112.53M
-
-
-
-
Target Price
-
52W Range
0.0-4145.837
52W High
-
52W Low
-
RSI
71.62
Rel Volume
4.79
Avg Volume
1.36M
Volume
6.53M
Perf Week
0.26%
Perf Month
1.1%
Perf Quarter
-
Perf Half Y
1.63%
-
-
-
-
Beta
0.781
-
-
Volatility
2.39%, 12.56%
Prev Close
0.05%
Price
3866
Change
0%
DPH.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.69 | 4.98 | 5.59 | 6.26 | 6.67 | |
Net income per share | 0.3 | 0.33 | 0.51 | 0.53 | -0.24 | |
Operating cash flow per share | 0.8 | 1.03 | 0.82 | 1.13 | 0.56 | |
Free cash flow per share | 0.58 | 0.55 | -0.42 | 0.42 | 0.29 | |
Cash per share | 0.78 | 2.2 | 1.09 | 1.11 | 0.65 | |
Book value per share | 4.95 | 6.16 | 5.82 | 6.12 | 6.62 | |
Tangible book value per share | -1.73 | -0.53 | -0.76 | -0.58 | -1.47 | |
Share holders equity per share | 4.95 | 6.16 | 5.82 | 6.12 | 6.62 | |
Interest debt per share | 3.1 | 3.54 | 3.02 | 3.13 | 4.81 | |
Market cap | 2.83B | 2.95B | 4.75B | 3.77B | 4.21B | |
Enterprise value | 3.06B | 3.07B | 4.95B | 3.98B | 4.64B | |
P/E ratio | 91.59 | 86.88 | 85.63 | 64.76 | -150.74 | |
Price to sales ratio | 5.87 | 5.72 | 7.82 | 5.53 | 5.52 | |
POCF ratio | 34.6 | 27.68 | 53.34 | 30.67 | 66.12 | |
PFCF ratio | 47.72 | 51.49 | -103.99 | 83.2 | 126.29 | |
P/B Ratio | 5.56 | 4.62 | 7.51 | 5.65 | 5.57 | |
PTB ratio | 5.56 | 4.62 | 7.51 | 5.65 | 5.57 | |
EV to sales | 6.35 | 5.97 | 8.15 | 5.83 | 6.09 | |
Enterprise value over EBITDA | 24.94 | 23.46 | 30.57 | 15.69 | 47.25 | |
EV to operating cash flow | 37.38 | 28.88 | 55.58 | 32.36 | 72.89 | |
EV to free cash flow | 51.57 | 53.72 | -108.37 | 87.79 | 139.21 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.02 | -0.01 | |
Free cash flow yield | 0.02 | 0.02 | -0.01 | 0.01 | 0.01 | |
Debt to equity | 0.61 | 0.56 | 0.5 | 0.49 | 0.67 | |
Debt to assets | 0.29 | 0.29 | 0.26 | 0.25 | 0.32 | |
Net debt to EBITDA | 1.86 | 0.97 | 1.24 | 0.82 | 4.38 | |
Current ratio | 2.47 | 3.27 | 2.52 | 2.8 | 2.85 | |
Interest coverage | 3.71 | 4.54 | 8.57 | 7.83 | 0.14 | |
Income quality | 2.1 | 2.04 | 1.06 | 1.29 | 10.1 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.92 | 0.98 | 0.68 | 0.77 | -1.85 | |
Sales general and administrative to revenue | 0.26 | 0.26 | 0.25 | 0.26 | 0.47 | |
Research and developement to revenue | 0.05 | 0.06 | 0.05 | 0.05 | 0.08 | |
Intangibles to total assets | 0.66 | 0.56 | 0.59 | 0.56 | 0.59 | |
Capex to operating cash flow | -0.28 | -0.46 | -1.51 | -0.63 | -0.48 | |
Capex to revenue | -0.05 | -0.1 | -0.22 | -0.11 | -0.04 | |
Capex to depreciation | -2.3 | -3.46 | -8.7 | -0.87 | -0.34 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.79 | 6.74 | 8.17 | 8.57 | 6.03 | |
ROIC | 0.05 | 0.04 | 0.07 | 0.07 | 0 | |
Return on tangible assets | 0.09 | 0.06 | 0.11 | 0.1 | -0.04 | |
Graham Net | -3.3 | -2.44 | -2.96 | -2.99 | -4.58 | |
Working capital | 174M | 311.6M | 236.4M | 285.7M | 303.9M | |
Tangible asset value | -177.9M | -54.7M | -82.9M | -63.7M | -167.2M | |
Net current asset value | -247.3M | -151.2M | -189M | -182.1M | -346.3M | |
Invested capital | 0.61 | 0.56 | 0.5 | 0.49 | 0.67 | |
Average receivables | 45.55M | 85.25M | 83.8M | 105.15M | 133.15M | |
Average payables | 85.6M | 96.85M | 105.85M | 125.15M | 140.65M | |
Average inventory | 95.3M | 112.4M | 135.15M | 162.6M | 196.5M | |
Days sales outstanding | 69.02 | 56.26 | 52.95 | 65.37 | 69.12 | |
Days payables outstanding | 167.02 | 160.37 | 158.06 | 168.12 | 157.35 | |
Days of inventory on hand | 181.89 | 197.28 | 208.19 | 215.93 | 236.62 | |
Receivables turnover | 5.29 | 6.49 | 6.89 | 5.58 | 5.28 | |
Payables turnover | 2.19 | 2.28 | 2.31 | 2.17 | 2.32 | |
Inventory turnover | 2.01 | 1.85 | 1.75 | 1.69 | 1.54 | |
ROE | 0.06 | 0.05 | 0.09 | 0.09 | -0.04 | |
Capex per share | -0.22 | -0.48 | -1.24 | -0.71 | -0.27 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q4
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.6 | 1.66 | 1.66 | 1.69 | 1.69 | |
Net income per share | 0.08 | 0.1 | 0.1 | -0.22 | -0.22 | |
Operating cash flow per share | 0.16 | 0.23 | 0.23 | 0.05 | 0.05 | |
Free cash flow per share | 0.12 | 0.18 | 0.18 | 0 | 0 | |
Cash per share | 1.11 | 0.77 | 0.77 | 0.65 | 0.65 | |
Book value per share | 6.11 | 7.39 | 7.39 | 6.63 | 6.63 | |
Tangible book value per share | -0.58 | -2.37 | -2.37 | -1.42 | -1.47 | |
Share holders equity per share | 6.11 | 7.39 | 7.39 | 6.63 | 6.63 | |
Interest debt per share | 3.04 | 4.4 | 4.53 | 4.34 | 4.49 | |
Market cap | 3.77B | 2.98B | 2.98B | 3.02B | 4.2B | |
Enterprise value | 3.98B | 2.9B | 3.4B | 2.94B | 4.63B | |
P/E ratio | 107.77 | 66.03 | 65.93 | -29.87 | -41.55 | |
Price to sales ratio | 21.59 | 15.82 | 15.79 | 15.71 | 21.85 | |
POCF ratio | 216.79 | 115.9 | 115.72 | 498.72 | 693.69 | |
PFCF ratio | 293.55 | 145.58 | 145.36 | -30.17K | -41.97K | |
P/B Ratio | 5.66 | 3.55 | 3.54 | 4 | 5.56 | |
PTB ratio | 5.66 | 3.55 | 3.54 | 4 | 5.56 | |
EV to sales | 22.78 | 15.35 | 18.04 | 15.32 | 24.09 | |
Enterprise value over EBITDA | 112.44 | 104.38 | 122.64 | 878.46 | 1.38K | |
EV to operating cash flow | 228.75 | 112.49 | 132.16 | 486.42 | 764.78 | |
EV to free cash flow | 309.75 | 141.3 | 166.01 | -29.43K | -46.27K | |
Earnings yield | 0 | 0 | 0 | -0.01 | -0.01 | |
Free cash flow yield | 0 | 0.01 | 0.01 | 0 | 0 | |
Debt to equity | 0.49 | 0.59 | 0.61 | 0.65 | 0.67 | |
Debt to assets | 0.25 | 0.28 | 0.29 | 0.31 | 0.32 | |
Net debt to EBITDA | 5.88 | -3.17 | 15.25 | -22.21 | 128.39 | |
Current ratio | 2.8 | 2.73 | 2.73 | 2.85 | 2.85 | |
Interest coverage | 8.53 | 5.27 | 5.27 | -2.22 | -2.22 | |
Income quality | 1.99 | 2.28 | 2.28 | -0.24 | -0.24 | |
Dividend Yield | 0 | 0.01 | 0.01 | 0 | 0 | |
Payout ratio | 0.74 | 1.65 | 1.65 | -0.28 | -0.28 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.16 | 0.07 | 0.07 | 0.16 | 0.16 | |
Intangibles to total assets | 0.56 | 0.64 | 0.64 | 0.58 | 0.59 | |
Capex to operating cash flow | -0.26 | -0.2 | -0.2 | -1.02 | -1.02 | |
Capex to revenue | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 | |
Capex to depreciation | -0.25 | -1.22 | -1.22 | -0.3 | -0.3 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | -0.01 | -0.01 | |
Graham number | 3.32 | 4.06 | 4.06 | 5.75 | 5.75 | |
ROIC | 0.01 | 0.01 | 0.01 | -0.01 | -0.01 | |
Return on tangible assets | 0.02 | 0.02 | 0.02 | -0.04 | -0.04 | |
Graham Net | -3.83 | -5.34 | -5.34 | -4.59 | -4.59 | |
Working capital | 285.7M | 290.9M | 290.9M | 303.9M | 303.9M | |
Tangible asset value | -63.7M | -269.5M | -269.5M | -162.1M | -167.2M | |
Net current asset value | -182.1M | -443.3M | -443.3M | -346.3M | -346.3M | |
Invested capital | 0.49 | 0.59 | 0.61 | 0.65 | 0.67 | |
Average receivables | 0 | 62.95M | 125.9M | 135.05M | 144.2M | |
Average payables | 91.4M | 138.05M | 139.3M | 91.35M | 93.95M | |
Average inventory | 175.7M | 199.75M | 223.8M | 220.55M | 217.3M | |
Days sales outstanding | 0 | 60.05 | 60.05 | 67.58 | 67.58 | |
Days payables outstanding | 160.63 | 157.8 | 157.8 | 45.16 | 150.35 | |
Days of inventory on hand | 206.3 | 253.52 | 253.52 | 226.09 | 226.09 | |
Receivables turnover | 0 | 1.5 | 1.5 | 1.33 | 1.33 | |
Payables turnover | 0.56 | 0.57 | 0.57 | 1.99 | 0.6 | |
Inventory turnover | 0.44 | 0.36 | 0.36 | 0.4 | 0.4 | |
ROE | 0.01 | 0.01 | 0.01 | -0.03 | -0.03 | |
Capex per share | -0.04 | -0.05 | -0.05 | -0.05 | -0.05 |
DPH.L Frequently Asked Questions
What is Dechra Pharmaceuticals PLC stock symbol ?
Dechra Pharmaceuticals PLC is a GB stock and trading under the symbol DPH.L
What is Dechra Pharmaceuticals PLC stock quote today ?
Dechra Pharmaceuticals PLC stock price is $3866 today.
Is Dechra Pharmaceuticals PLC stock public?
Yes, Dechra Pharmaceuticals PLC is a publicly traded company.